Bilirubin Metabolism and its Disorders

Zakim and Boyer's Hepatology

Volumn , Issue , 2012, Pages 1079-1109

  Roy Chowdhury, Jayanta ^a,b   Roy Chowdhury, Namita ^a,b  

^a Division of Digestive and Liver Disease   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882562441     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-0881-3.00062-0     Document Type: Chapter

References (518)

1. Chen TS, Chen PS Understanding the liver. A history 1984, Greenwood Press, Westport, CT, 99.
2. Berk PD, et al. Studies on bilirubin kinetics in normal adults. J Clin Invest 1979, 48:2176.
3. London IM, et al. On the origin of bile pigment in normal man. J Biol Chem 1950, 184:351.
4. 14C. J Lab Clin Med 1971, 78:411.
5. Grandchamp B, et al. Formation and disposition of newly synthesized heme in adult rat hepatocytes in primary cultures. J Biol Chem 1981, 256:11677.
6. Levitt M, et al. The nonerythropoietic component of early bilirubin. J Clin Invest 1968, 47:1281.
7. Robinson SH, Tsong M Hemolysis of "stress" reticulocytes: a source of erythropoietic bilirubin formation. J Clin Invest 1970, 49:1025.
8. Come SE, Shohet SB, Robinson SH Surface remodeling vs. whole-cell hemolysis of reticulocytes produced with erythroid stimulation or iron deficiency anemia. Blood 1974, 44:817.
9. Tenhunen R, Marver HS, Schmidt R Microsomal heme oxygenase: characterization of the enzyme. J Biol Chem 1969, 244:6388.
10. 18O]oxygen labeling. Biochem J 1978, 170:297.
11. Yoshida T, Kikuchi G Features of the reaction of heme degradation catalyzed by the reconstituted microsomal hemeoxygenase system. J Biol Chem 1978, 53:4230.
12. Maines MD, Trakshel GM, Kutty RK Characterization of two constitutive forms of rat liver microsomal heme oxygenase. Only one molecular species of the enzyme is inducible. J Biol Chem 1986, 261:411.
13. Bissel DM, Hammaker L, Schmid R Liver sinusoidal cells. Identification of a subpopulation for erythrocyte catabolism. J Cell Biol 1972, 54:107.
14. Makino N, et al. Altered expression of heme oxygenase-1 in the livers of patients with portal hypertensive diseases. Hepatology 2001, 33:32.
15. Fernandez M, Bonkovsky HL Increased heme oxygenase-1 gene expression in liver cells and splanchnic organs from portal hypertensive rats. Hepatology 1999, 29:1672.
16. Nishikawa Y, et al. In vivo role of heme oxygenase in ischemic coronary vasodilation. Am J Physiol Heart Circ Physiol 2004, 286:H2296.
17. Rattan S, Al Haj R, De Godoy MA Mechanism of internal anal sphincter relaxation by CORM-1, authentic CO, and NANC nerve stimulation. Am J Physiol Gastrointest Liver Physiol 2004, 287:G605.
18. Yoshinaga T, Sassa S, Kappas A The occurrence of molecular interactions among NADPH-cytochrome C reductase, heme oxygenase and biliverdin reductase in heme degradation. J Biol Chem 1982, 257:7778.
19. Cornelius CE Comparative bile pigment metabolism in vertebrates. Bile pigments and jaundice 1986, 601. Marcel Dekker, New York. J.D. Ostrow (Ed.).
20. McDonagh AF, Palma LA, Schmid R Reduction of biliverdin and placental transfer of bilirubin and biliverdin in the pregnant guinea pig. Biochem J 1981, 194:273.
21. Roy Chowdhury J, Roy Chowdhury N, Arias IM Bilirubin conjugates in the spiny dogfish, Squalus acanthias, the small skate, Raja erinacea and the winter flounder Pseudopleuronectes americanas. Comp Biochem Physiol 1980, 66b:523.
22. Roy Chowdhury N, Roy Chowdhury J, Arias IM Bile pigment composition and hepatic UDP-glucuronyl transferase activity in adult and fetal dogfish shark Squalus acanthias. Comp Biochem Physiol 1982, 73B:651.
23. Huang TJ, Trakshel GM, Maines MD Detection of ten variants of biliverdin reductase in rat liver by two-dimensional gel electrophoresis. J Biol Chem 1989, 264:7844.
24. Fakhrai H, Maines MD Expression and characterization of a rat kidney biliverdin reductase: evidence suggesting that the liver and kidney enzymes are the same gene transcript product. J Biol Chem 1992, 267:4023.
25. Nakao A, et al. Biliverdin protects the functional integrity of a transplanted syngeneic small bowel. Gastroenterology 2004, 127:595.
26. Yamashita K, et al. Biliverdin, a natural product of heme catabolism, induces tolerance to cardiac allografts. FASEB J 2004, 18:765.
27. Fulks M, Stout RL, Dolan VF Mortality associated with bilirubin levels in insurance applicants. J Insur Med 2009, 41:49.
28. Breimer LH, et al. Serum bilirubin and risk of ischemic heart disease in middle-aged British men. Clin Chem 1995, 41:1504.
29. Zucker SD, Horn PS, Serman KE Serum bilirubin levels in the US population: gender effect and inverse correlation with colorectal cancer. Hepatology 2004, 40:827.
30. Temme EHM, et al. Serum bilirubin and 10-year mortality risk in a Belgian population. Cancer Causes Control 2001, 12:887.
31. Lin Y-C, et al. Variants in the UGT1A1 gene and the risk of pediatric nonalcoholic fatty liver disease. Peditrics 2009, 124:e1221.
32. Wegiel B, et al. Cell surface biliverdin reductase mediates biliverdin-induced anti-inflammatory effects via phosphatidylinositol 3-kinase and Akt. J Biol Chem 2009, 284:21369.
33. Brink MA, et al. Enterohepatic cycling of bilirubin: a putative mechanism for pigment gallstone formation in ileal Crohn's disease [see comments]. Gastroenterology 1999, 116:1420.
34. Brink MA, Mendezsanchez N, Carey MC Bilirubin cycles enterohepatically after ileal resection in the rat. Gastroenterology 1996, 110:1945.
35. Dhar GJ Enterohepatic circulation and plasma transport of urobilinogen. Bile pigments: chemistry and physiology 1977, 526. Department of Health, Education, and Welfare, National Institutes of Health, Washington. P.D. Berk, N.I. Berlin (Eds.).
36. 3H in man. J Clin Invest 1972, 51:2450.
37. Jones EA, et al. Quantitation of hepatic bilirubin synthesis in man. In: Berk PD, Berlin NI, editors. The chemistry and physiology of bile pigments. Washington: USDEW, NIH, 1977: 189.
38. Berk PD, et al. Comparison of plasma bilirubin turnover and carbon monoxide production in man. J Lab Clin Med 1974, 83:29.
39. Engel RR Alternative sources of carbon monoxide. Bile pigments: chemistry and physiology 1977, 148. U.S. Department of Health, Education, and Welfare, National Institutes of Health, Washington. P.D. Berk, N.I. Berlin (Eds.).
40. Westlake DWS, Roxburgh JM, Talbot G Microbial production of carbon monoxide from flavinoids. Nature 1961, 189:510.
41. Merritt JE, Loening KL Nomenclature of tetrapyrroles. Pure Appl Chem 1979, 51:2251.
42. Fischer H, Plieninger H Synthese des biliverdins (uteroverdins) und bilirubins der biliverdine XIII, und III, sowie der Vinulneoxanthosaure. Hoppe Seylers A Physiol Chem 1942, 274:231.
43. Bonnet RJ, Davis E, Hursthouse MB Structure of bilirubin. Nature 1976, 262:326.
44. Gray CH, Kulszycka A, Nicholson DC The chemistry of bile pigments, IV. Spectrophotometric titration of the bile pigments. J Chem Soc 1961, 442:2276.
45. Krasner J, Yaffe SJ The automatic titration of bilirubin. Biochem Med 1973, 7:128.
46. Brodersen R Aqueous solubility, albumin binding and tissue distribution of bilirubin. Bile pigments and jaundice 1986, 157. Marcel Dekker, New York. J.D. Ostrow (Ed.).
47. Brodersen R Free bilirubin in the blood plasma of the newborn. Effects of albumin, fatty acids, pH, displacing drugs and phototherapy. Appendix A: Provisional survey of the bilirubin displacing effect of 150 drugs. Intensive care of the newborn 1978, Vol. 2:331. Masson, New York.
48. Fog J, Jellum E Structure of bilirubin. Nature 1963, 198:88.
49. Kuenzle CC, Weibel MH, Pelloni RR A proposed novel structure for the metal chelates of bilirubin. Biochem J 1973, 130:1147.
50. Kuenzle CC, Weibel MH, Pelloni RR The reaction of bilirubin with diazomethane. Biochem J 1973, 133:357.
51. Lightner DA, Wooldridge TA, McDonagh AF Configurational isomerization of bilirubin and the mechanism of phototherapy. Biochem Biophys Res Commun 1979, 86:235.
52. Yang BJ, et al. Resonance Raman spectrometry of bilirubins: band assignments and application to bilirubin/lipid complexation. Biochemistry 1991, 30:688.
53. McDonagh AF Bilitrienes and 5,15 biladines. The porphyrins, Vol. VI, Bile pigments 1979, 293. Academic Press, New York. D. Dolphin (Ed.).
54. Trull FR, Ibars O, Lightner DA Conformational inversion of bilirubin formed by reduction of the biliverdin-human serum albumin complex: evidence from circular dichroism. Arch Biochem Biophys 1992, 298:710.
55. McDonagh AF, Pu YM, Lightner DA Effect of volatile anesthetics on the circular dichroism of bilirubin bound to human serum albumin. Experientia 1992, 48:246.
56. Moan J Light therapy of newborns with hyperbilirubinemia (translated from Norwegian). Tidsskr Norske Laegefor 1992, 112:1459.
57. Agati G, Fusi F, Pratesi R Evaluation of the quantum yield for E to Z isomerization of bilirubin bound to human serum albumin. Evidence of internal conversion processes competing with configurational photoisomerization. J Photochem Photobiol 1993, 17:173.
58. Itoh S, Onishi S Kinetic study of the photochemical changes of (ZZ)-bilirubin IX′ bound to human serum albumin. Demonstration of (EZ)-bilirubin IX′ as an intermediate in photochemical changes from (ZZ)-bilirubin I″ to (EZ)-cyclobilirubin IX.″. Biochem J 1985, 226:251.
59. Ennever JF, Dreising TJ Quantum yields for the cyclization and configurational isomerization of 4E, 15Z bilirubin. Photochem Photobiol 1991, 53:25.
60. McDonagh AF, Palma LA, Lightner DA Phototherapy for neonatal jaundice. Stereospecific and regiospecific photoisomerization of bilirubin bound to human serum albumin and NMR characterization of intramolecularly cyclized photoproducts. J Am Chem Soc 1982, 104:6867.
61. Cu A, Bellah GG, Lightner DA On the fluorescence of bilirubin. J Am Chem Soc 1975, 97:2579.
62. Lightner DA Products of bilirubin photodegradation. Chemistry and physiology of bile pigments 1977, 93. Department of Health, Education, and Welfare, National Institutes of Health, Washington. N.I. Berlin, P.D. Berk, C.J. Watson (Eds.).
63. McDonagh AF Thermal and photochemical reactions of bilirubin IX. Ann N Y Acad Sci 1975, 244:553.
64. Mollison PL, Cutbush M Hemolytic disease of the newborn: criteria of severity. Br Med J 1949, 1:123.
65. Hsia DYY, et al. Erythroblastosis fetalis, VIII. Studies of serum bilirubin in relation to kernicterus. N Engl J Med 1952, 247:668.
66. 14C into the central nervous system. J Clin Invest 1966, 45:678.
67. Takahashi M, et al. Penetration of bilirubin into the brain of albumin-deficient and jaundiced rats (AJR) and Nagase analbuminemic rats (NAR). J Biochem 1984, 96:1705.
68. Sata H, Temba R Relationship between plasma unbound bilirubin concentration and cerebellar bilirubin content in homozygous Gunn rat sucklings. Experientia 1978, 34:221.
69. Jew JY, Williams TH Ultrastructural aspects of bilirubin encephalopathy in cochlear nuclei of the Gunn rat. J Anat 1977, 124:599.
70. Sapiro SM Reversible brainstem auditory evoked potential abnormalities in jaundiced Gunn rats given sulfonamide. Pediatr Res 1993, 34:629.
71. Takagishi Y, Yamamura H Purkinje cell abnormalities and synaptogenesis in genetically jaundiced rats (Gunn rats). Brain Res 1989, 492:116.
72. Schutta HS, Johnson L, Neville HS Mitochondrial abnormalities in bilirubin encephalopathy. J Neuropathol Exp Neurol 1970, 29:296.
73. Sato H, et al. Different behaviours among lysosomal enzymes in the cerebellum of jaundiced Gunn rats with cerebellar hypoplasia. J Neurochem 1987, 48:1823.
74. Aono S, et al. Cyclic nucleotides and the activity of glia maturation factor in the hypoplastic cerebellum of developing jaundiced Gunn rats. J Neurochem 1988, 50:700.
75. Labrune PH, et al. Cerebellar symptoms as the presenting manifestations of bilirubin encephalopathy in children with Crigler-Najjar type I disease. Pediatrics 1992, 89:768.
76. Conlee JW, Shapiro SM Morphological changes in the cochlear nucleus and nucleus of the trapezoid body in Gunn rat pups. Hearing Res 1991, 57:23.
77. Shapiro SW, Conlee JW Brainstem auditory evoked potentials correlate with morphological changes in Gunn rat pups. Hearing Res 1991, 57:16.
78. Shapiro SM Binaural effects in brainstem auditory evoked potentials of jaundiced Gunn rats. Hearing Res 1991, 53:41.
79. Zuelzer WW, Mudgett RT Kernicterus. Etiologic study based on an analysis of 55 cases. Pediatrics 1950, 6:452.
80. Vaughan VC, Allen FC, Diamond LK Erythroblastosis fetalis. IV. Further observations on kernicterus. Pediatrics 1950, 6:706.
81. Lucey JF Bilirubin and brain damage-a real mess. Pediatrics 1982, 69:381.
82. Turkel SB, et al. A clinical pathologic reappraisal of kernicterus. Pediatrics 1982, 69:267.
83. Van de Bor M, et al. Hyperbilirubinemia in low birth weight infants and outcome at 5 years of age. Pediatrics 1992, 89:359.
84. Rappaport SI Sites and functions of blood-brain barrier. Blood-brain barrier in physiology and medicine 1976, 43. Raven Press, New York.
85. Purpura DP, Carmichael MW Characteristics of blood-brain barrier to gamma-aminobutyric acid in neonatal cat. Science 1960, 131:410.
86. Cornford EM, et al. Comparison of lipid-mediated blood-brain barrier penetrability in neonates and adults. Am J Physiol 1982, 243:C161.
87. Laas R, Helmke K Regional cerebral blood flow following unilateral blood-brain barrier alteration induced by hyperosmolar perfusion in the albino rat. Cerebral circulation and metabolism 1981, 317. Raven Press, New York. J. Cervos-Navarro, E. Fritschka (Eds.).
88. Levine RL, Fredericks WR, Rappaport SI Clearance of bilirubin from rat brain after reversible osmotic opening of the blood-brain barrier. Pediatr Res 1985, 19:1040.
89. Lee K-S, Gartner LM Management of unconjugated hyperbilirubinemia in the newborn. Semin Liver Dis 1983, 3:52.
90. Cordon-Cardo C, et al. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci U S A 1989, 86:695.
91. Rao VV, et al. Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal fluid-drug permeability barrier. Proc Natl Acad Sci U S A 1999, 96:3900.
92. Wijnholds J, et al. Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier. J Clin Invest 2000, 105:279.
93. Zhang Y, et al. Expression of various multidrug resistance-associated protein (MRP) homologues in brain microvessel endothelial cells. Brain Res 2000, 876:148.
94. Brito MA, et al. Bilirubin injury to neurons: contribution of oxidative stress and rescue by glycoursodeoxycholic acid. Neurotoxicology 2008, 29:259-269.
95. Cesaratto L, et al. Bilirubin-induced cell toxicity involves PTEN activation through an APE1/Ref-1-dependent pathway. J Mol Med 2007, 85:1099-1112.
96. Deganuto M, et al. A proteomic approach to the bilirubin-induced toxicity in neuronal cells reveals a protective function of DJ-1 protein. Proteomics 2010, 10:1645.
97. Mustafa MG, Cowger ML, Kind TE Effects of bilirubin on mitochondrial reactions. J Biol Chem 1969, 244:6403.
98. Roger C, et al. Effects of bilirubin infusion on cerebral glucose utilization in the immature rat. Dev Brain Res 1993, 76:115.
99. Rudman D, Bixler TJ, Del Rio AE Effect of free fatty acid on binding of drugs by bovine serum albumin, by human serum albumin and by rabbit serum. J Pharmacol Exp Ther 1971, 176:261.
100. Brodersen R, et al. Kinetics of bilirubin oxidation with peroxidase, as applied to studies of bilirubin-albumin binding. Scand J Clin Lab Invest 1979, 39:143.
101. Constantopoulos A, Matsaniotis N Bilirubin inhibition of protein kinase: its prevention by cyclic AMP. Cytobios 1976, 17:17.
102. Morphis I, et al. Bilirubin-induced modulation of cerebral protein phosphorylation in neonate rabbits in vivo. Science 1982, 218:156.
103. Sano K, Nakamura H, Tamotsu M Mode of inhibitory action of bilirubin on protein kinase C. Pediatr Res 1985, 19:587.
104. Martinez-Maldonado M, Suki WN, Schenker S Nature of the urinary concentrating defect in the Gunn strain of rat. Am J Physiol 1969, 216:1386.
105. Zuelzer WW, Mudgett RT Kernicterus. Etiologic study based on an analysis of 55 cases. Pediatrics 1950, 6:452.
106. Odell GB, et al. Protection from bilirubin nephropathy in jaundiced Gunn rats. Gastroenterology 1974, 66:1218.
107. Engle WD, Avant BS Neonatal hyperbilirubinemia and renal function. J Pediatr 1982, 100:113.
108. Axelson RA Spontaneous renal papillary necrosis in the Gunn rat. Pathology 1973, 5:43.
109. Brodersen R Bilirubin solubility and interaction with albumin and phospholipid. J Biol Chem 1979, 254:2364.
110. Gitzelmann-Cumarasamy N, Kuenzle CC, Wilson KJ Mapping of the primary bilirubin binding site of human serum albumin. Experientia 1976, 32:768.
111. Jacobsen C Lysine residue 240 of human serum albumin is involved in high-affinity binding of bilirubin. Biochem J 1978, 171:453.
112. Odell GB, Cohen SN, Gordes EH Administration of albumin in the management of hyperbilirubinemia by exchange transfusion. Pediatrics 1962, 30:613.
113. Brodersen R Bilirubin solubility and interaction with albumin and phospholipid. J Biol Chem 1979, 254:2364.
114. Odell GB The dissociation of bilirubin from albumin and its clinical implications. J Pediatr 1959, 55:268.
115. Schmid R, et al. Interaction of bilirubin with albumin. Nature 1965, 204:1041.
116. Kapitulnik J, et al. Clinical evaluation of Sephadex gel filtration in estimation of bilirubin binding in serum in neonatal jaundice. Arch Dis Child 1974, 49:886.
117. Brodersen R, et al. Kinetics of bilirubin oxidation with peroxidase, as applied to studies of bilirubin-albumin binding. Scand J Clin Lab Invest 1979, 39:143.
118. Athanassiadis S, et al. An electrophoretic method for detection of unbound bilirubin and reserve bilirubin binding capacity in serum of newborns. J Lab Clin Med 1974, 83:968.
119. Lamolla AA, et al. Fluorometric study of the partition of bilirubin among blood components: basis for rapid microassays of bilirubin and bilirubin binding capacity in whole blood. Anal Biochem 1979, 15:25.
120. Brodersen R Determination of the vacant amount of high affinity bilirubin binding site on serum albumin. Acta Pharmacol Toxicol 1978, 42:153.
121. Hsia JC, et al. Development of a spin assay for reserve bilirubin loading capacity of human serum. Proc Natl Acad Sci USA 1978, 75:1542.
122. Weiss JS, et al. The clinical importance of a protein-bound fraction of serum bilirubin in patients with hyperbilirubinemia. N Engl J Med 1983, 309:147.
123. Inoue M, et al. Plasma clearance of sulfobromophthalein and its interaction with hepatic binding proteins in normal and analbuminemic rats: is plasma albumin essential for vectorial transport of organic anions in the liver?. Proc Natl Acad Sci U S A 1983, 80:7654.
124. Inoue M, et al. The role of albumin in the hepatic transport of bilirubin: studies in mutant analbuminemic rats. J Biochem 1985, 97:737.
125. Yamazaki M, et al. Uptake of organic anions by isolated rat hepatocytes: a classification in terms of ATP-dependency. J Hepatol 1992, 14:41.
126. Kouzuki H, et al. Contribution of sodium taurocholate co-transporting polypeptide to the uptake of its possible substrates into rat hepatocytes. J Pharmacol Exp Ther 1998, 286:1043.
127. Zucker SD, Goessling W Mechanism of hepatocellular uptake of albumin-bound bilirubin. Biochim Biophys Acta 2000, 1463:197.
128. Cui Y, et al. Hepatic uptake of bilirubin and its conjugates by the human organic anion-transporting polypeptide 2 (symbol SLC21A6). J Biol Chem 2000, 276:9626.
129. Suzuki H, Sugiyama Y Transport of drugs across the hepatic sinusoidal membrane: sinusoidal drug influx and efflux in the liver. Semin Liver Dis 2000, 20:251.
130. Wang P, et al. The human organic anion transport protein SLC21A6 (OATP2) is not sufficient for bilirubin transport. J Biol Chem 2003, 278:20695.
131. Webster CR, et al. Cell swelling-induced translocation of rat liver Na+/taurocholate cotransport polypeptide is mediated via the phosphoinositide 3-kinase signaling pathway. J Biol Chem 2000, 275:29754.
132. Dranoff JA, et al. Short-term regulation of bile acid uptake by microfilament-dependent translocation of rat ntcp to the plasma membrane. Hepatology 1999, 30:223.
133. Ganguly TC, et al. Regulation of the rat liver sodium-dependent bile acid cotransporter gene by prolactin. Mediation of transcriptional activation by Stat5. J Clin Invest 1997, 99:2906.
134. Denson LA, et al. Interleukin-1α suppresses retinoid transactivation of two hepatic transporter genes involved in bile formation. J Biol Chem 2000, 275:8835.
135. Trauner M, et al. Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors. J Clin Invest 1998, 101:2092.
136. Beigneux AP, et al. The acute phase response is associated with retinoid X receptor repression in rodent liver. J Biol Chem 2000, 275:16390.
137. Jedlitschky G, et al. ATP-dependent transport of bilirubin glucuronides by the multidrug resistance protein MRP1 and its hepatocyte canalicular isoform MRP2. Biochem J 1997, 327:305.
138. Vos TA, et al. Up-regulation of the multidrug resistance genes, mrp1 and mdr1b, and down-regulation of the organic anion transporter, mrp2, and the bile salt transporter, spgp, in endotoxemic rat liver. Hepatology 1998, 28:1637.
139. Trauner M, et al. The rat canalicular conjugate export pump (mrp2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology 1997, 113:255.
140. Konig J, et al. Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane. Hepatology 1999, 29:1156.
141. Hirohashi T, Suzuki H, Sugiyama Y Characterization of the transport properties of cloned rat multidrug resistance-associated protein 3 (MRP3). J Biol Chem 1999, 274:15181.
142. Jansen PLM, Cuypers HT, Peters WHM Quantitation of bilirubin conjugates with high-performance liquid chromatography in patients with low total serum bilirubin levels. Eur J Clin Invest 1984, 14:295.
143. Jansen PLM, Peters WHM, Jansssens AR Clinical value of serum bilirubin subfractionation by high-performance liquid chromatography and conventional methods in patients with primary biliary cirrhosis. J Hepatol 1986, 2:485.
144. Levi AJ, Gatmaitan Z, Arias IM Two hepatic cytoplasmic protein fractions, Y and Z, and their possible role in the hepatic uptake of bilirubin, sulfobromophthalein, and other anions. J Clin Invest 1969, 48:2156.
145. Rowe JD, Nieves E, Listowsky I Subunit diversity and tissue distribution of human glutathione S-transferases: interpretations based on electrospray ionization-MS and peptide sequence-specific antisera. Biochem J 1997, 325:481.
146. Wolkoff AW, et al. Role of ligandin in transfer of bilirubin from plasma into liver. Am J Physiol 1979, 236:E638.
147. Compernolle F, et al. Mass-spectrometric structure elucidation of a dog bile axopigments as the acyl glycosides of glucopyranose and xylopyranose. Biochem J 1971, 125:811.
148. Fevery JB, et al. Bilirubin conjugates in bile of man and rat in the normal state and in liver disease. J Clin Invest 1972, 51:2482.
149. Spivak W, Carey MC Reverse-phase HPLC separation, quantification and preparation of bilirubin and its conjugates from native bile. Biochem J 1985, 225:787.
150. Fevery J, et al. Excretion in dog bile of glucose and xylose conjugates of bilirubin. Biochem J 1971, 125:803.
151. Roy Chowdhury J, et al. Distribution of UDP-glucuronosyltransferase in rat tissue. Proc Natl Acad Sci U S A 1985, 82:2990.
152. Dutton GJ, Burchell B Newer aspects of glucuronidation. Prog Drug Metab 1977, 2:1.
153. Zakim D, Eibl H The influence of charge and the distribution of charge in the polar region of phospholipids on the activity of UDP-glucuronosyltransferase. J Biol Chem 1992, 267:13166.
154. Henderson P Activation in vitro of rat hepatic UDP glucuronyltransferase by ultrasound. Life Sci 1970, 9:511.
155. Graham AD, Wood GC Factors affecting the response of microsomal UDP-glucuronyltransferase to membrane perturbants. Biochim Biophys Acta 1973, 311:45.
156. Vessey DA, Zakim D Regulations of microsomal enzymes by phospholipids. J Biol Chem 1971, 246:4649.
157. Meech R, Mackenzie PI Structure and function of uridine diphosphate glucuronosyltransferases. Clin Exp Pharmacol Physiol 1997, 24:907-915.
158. Hauser SC, Ziurys JC, Gollan JL A membrane transporter mediates access of uridine-5′-diphosphoglucuronic acid from the cytosol into the endoplasmic reticulum of rat hepatocytes. Implications for glucuronidation reactions. Biochim Biophys Acta 1988, 967:149.
159. Battaglia E, Radominska-Pandya A A functional role for histidyl residues of the UDP-glucuronic acid carrier in rat liver endoplasmic reticulum membranes. Biochemistry 1998, 37:258.
160. Bossuyt X, Blanckaert N Carrier-mediated transport of uridine diphosphoglucuronic acid across the endoplasmic reticulum membrane is a prerequisite for UDP-glucuronosyltransferase activity in rat liver. Biochem J 1997, 323:645.
161. Heirwegh KPM, Campbell M, Meuwissen JATP Compartmentation of membrane bound enzymes. Some basic concepts and consequences for kinetic studies. Conjugation reactions in drug biotransformation 1978, 191. Elsevier, Amsterdam. A. Aitio (Ed.).
162. Hallinan T Comparison of compartmented and of conformational phospholipid-constraint models for the intramembranous arrangement of UDP-glucuronyltransferase. Conjugation reactions in drug biotransformation 1978, 257. Elsevier, Amsterdam. A. Aitio (Ed.).
163. Wishart GF Functional heterogeneity of UDP glucuronosyl transferase as indicated by its differential development and inducibility by glucocorticoids. Biochem J 1978, 174:485.
164. Lillienblum W, Walli AK, Bock KW Differential induction of rat liver microsomal UDP-glucuronosyltransferase activities by various inducing agents. Biochem Pharmacol 1982, 31:907.
165. Roy Chowdhury J, et al. Differential regulation by triiodothyronine of substrate-specific uridinediphosphoglucuronate glucuronosyl transferases in rat liver. Biochim Biophys Acta 1983, 761:58.
166. Roy Chowdhury J, et al. Isolation and characterization of multiple forms of rat liver UDP-glucuronoate glucuronosyltransferase. Biochem J 1986, 233:827.
167. Mackenzie PI, et al. The UDP glucuronosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 1997, 7:255.
168. Lazard D, et al. Odorant signal termination by olfactory UDP glucuronosyl transferase. Nature 1991, 349:790.
169. Ritter JK, et al. A novel complex locus UGT1 encodes human bilirubin, phenol and other UDP-glucuronosyltransferase isozymes with identical carboxy termini. J Biol Chem 1992, 267:3257.
170. Van Es HHG, et al. Assignment of the human UDP-glucuronosyltransferase gene UGT1A1 to chromosome 2, region 2q37. Cytogenet Cell Genet 1993, 63:114.
171. Drake RR, et al. Application of 5-azido-UDP-glucose and 5-azido-UDP-glucuronic acid photoaffinity probes for the determination of the active site orientation of microsomal UDP-glucosyltransferases and UDP-glucuronosyltransferases. J Biol Chem 1992, 267:11360.
172. Mackenzie PI Expression of chimeric cDNAs in cell culture defines a region of UDP-glucuronosyltransferase involved in substrate selection. J Biol Chem 1990, 265:3432.
173. Bosma PJ, et al. Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man. J Biol Chem 1994, 269:17960.
174. Roy Chowdhury N, et al. Expression of specific UDP-glucuronosyltransferase isoforms in carcinogen-induced preneoplastic rat liver nodules. Hepatology 1991, 13:31.
175. Meijer DKF Transport and metabolism in the hepato-biliary system. Handbook of physiology. The gastrointestinal system 1989, Vol. III:717. Oxford University Press, New York.
176. Keppler D, Konig J Hepatic canalicular membrane 5: expression and localization of the conjugate export pump encoded by the MRP2 (cMRP/cMOAT) gene in liver. FASEB J 1997, 11:509.
177. Van Aubel RA, et al. Multidrug resistance protein Mrp2 mediates ATP-dependent transport of classic renal organic anion p-aminohippurate. Am J Physiol Renal Physiol 2000, 279:F713.
178. Van Aubel RA, et al. Expression and immunolocalization of multidrug resistance protein 2 in rabbit small intestine. Eur J Pharmacol 2000, 400:195.
179. Kamisako T, et al. Transport of monoglucuronosyl and bisglucuronosyl bilirubin by recombinant human and rat multidrug resistance protein 2. Hepatology 1999, 30:485.
180. Paulusma CC, et al. A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. Hepatology 1997, 25:1539.
181. Kartenbeck J, et al. Absence of the canalicular isoform of the MRP gene-encoded conjugate export pump from the hepatocytes in Dubin-Johnson syndrome. Hepatology 1996, 23:1061.
182. Paulusma CC, et al. Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science 1996, 271:1126.
183. Vos TA, et al. Regulation of hepatic transport systems involved in bile secretion during liver regeneration in rats. Hepatology 1999, 29:1833.
184. Hirohashi T, et al. Hepatic expression of multidrug resistance-associated protein-like proteins maintained in Eisai hyperbilirubinemic rats. Mol Pharmacol 1998, 53:1068.
185. Ogawa K, et al. Characterization of inducible nature of MRP3 in rat liver. Am J Physiol Gastrointest Liver Physiol 2000, 278:G438.
186. Keppler D, Konig J Hepatic secretion of conjugated drugs and endogenous substances. Semin Liver Dis 2000, 20:265.
187. Stockel B, et al. Characterization of the 5′-flanking region of the human multidrug resistance protein 2 (MRP2) gene and its regulation in comparison with the multidrug resistance protein 3 (MRP3) gene. Eur J Biochem 2000, 267:1347.
188. Kauffmann HM, et al. Induction of cMrp/cMoat gene expression by cisplatin, 2-acetylaminofluorene, or cycloheximide in rat hepatocytes. Hepatology 1997, 26:980.
189. Kauffman HM, et al. Influence of redox-active compounds and PXR-activators on human MRP1 and MRP2 gene expression. Toxicology 2002, 171:137.
190. Tanaka T, et al. The human multidrug resistance protein 2 gene: functional characterization of the 5′-flanking region and expression in hepatic cells. Hepatology 1999, 30:1507.
191. Kauffmann HM, Schrenk D Sequence analysis and functional characterization of the 5′-flanking region of the rat multidrug resistance protein 2 (mrp2) gene. Biochem Biophys Res Commun 1998, 245:325.
192. Gerloff T, et al. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J Biol Chem 1998, 273:10046.
193. Strautnieks SS, et al. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet 1998, 20:233.
194. Lecureur V, et al. Cloning and expression of murine sister of P-glycoprotein reveals a more discriminating transporter than MDR1/P-glycoprotein. Mol Pharmacol 2000, 57:24.
195. Green RM, Hoda F, Ward KL Molecular cloning and characterization of the murine bile salt export pump. Gene 2000, 241:117.
196. Van Mil SW, et al. Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11. Gastroenterology 2004, 127:379.
197. Kubitz R, et al. Benign recurrent intrahepatic cholestasis associated with mutations of the bile salt export pump. J Clin Gastroenterol 2006, 40:171.
198. Smit JJM, et al. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 1993, 75:451.
199. de Vree JM, et al. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc Natl Acad Sci USA 1998, 95:282.
200. Crawford AR, et al. Hepatic secretion of phospholipid vesicles in the mouse critically depends on mdr2 or mdr3 P-glycoprotein expression. Visualization by electron microscopy. J Clin Invest 1997, 100:2562.
201. Huang W, et al. Induction of bilirubin clearance by the constitutive androstane receptor. Proc Natl Acad Sci U S A 2003, 100:4156.
202. Roy-Chowdhury J, Locker J, Roy-Chowdhury N Nuclear receptors orchestrate detoxification pathways. Dev Cell 2003, 4:607.
203. Lester R, Schmid R Intestinal absorption of bile pigments. II. Bilirubin absorption in man. N Engl J Med 1963, 269:178.
204. Alonso EM, et al. Enterohepatic circulation of nonconjugated bilirubin in rats fed with human milk. J Pediatr 1991, 118:425.
205. Ostrow JD Absorption of bile pigments by the gall bladder. J Clin Invest 1967, 46:2035.
206. Brodersen R, Herman LS Intestinal reabsorption of unconjugated bilirubin: a possible contributing factor in neonatal jaundice. Lancet 1963, 1:1242.
207. Stoll MS, Lim CD, Gray CH Chemical variants of the uroblins. Bile pigments, chemistry and physiology 1977, 483. U.S. Government Printing Office, Washington, DC. P.D. Berk, N.I. Berlin (Eds.).
208. Fulop M, Sanson J, Brazeau P Dialyzability, protein binding, and renal excretion of plasma conjugated bilirubin. J Clin Invest 1965, 44:666.
209. Gollan JL, Dallinger KJC, Billing BH Excretion of conjugated bilirubin in the isolated perfused rat kidney. Clin Sci Mol Med 1978, 54:381.
210. Tanaka Y, et al. Increased renal expression of bilivubin glucronide transporters in a rat model of obstructive jaundice. Am J Physiol Gastrointest Liver Physiol 2002, 282:G656.
211. 14-bilirubin in experimental obstructive jaundice. Ann Surg 1966, 163:330.
212. 14 labeled bilirubin in children with biliary atresia. N Engl J Med 1966, 274:231.
213. McDonagh F, Palma LA, Lighner DA Phototherapy for neonatal jaundice. Stereospecific and regiospecific photoisomerization of bilirubin bound to human serum albumin and NMR characterization of intramolecularly cyclized photoproducts. J Am Chem Soc 1982, 104:6867.
214. Itoh S, Onishi S Kinetic study of the photochemical changes of (ZZ)-bilirubin IX bound to human serum albumin. Demonstration of (EZ)-bilirubin IX as an intermediate in photochemical changes from (ZZ)-bilirubin IX to (EZ)-cyclobilirubin IX. Biochem J 1985, 226:251.
215. Berry CS, Zarembo JE, Ostrow JD Evidence for conversion of bilirubin to dihydroxyl derivates in the Gunn rat. Biochem Biophys Res Commun 1972, 49:1366.
216. Kapitulnik J, Ostrow JD Stimulation of bilirubin catabolism in jaundiced Gunn rats by an inducer of microsomal mixed function mono-oxygenases. Proc Natl Acad Sci U S A 1978, 75:682.
217. Kapitulnik J, Bircher J, Hedorn HB Chlorpromazine reduces plasma bilirubin levels in Crigler-Najjar syndrome type I (CNS-I). Hepatology 1989, 10:A708.
218. Cohen AN, et al. Effects of phenobarbital on bilirubin metabolism and its response to phototherapy in the jaundiced Gunn rat. Hepatology 1985, 5:310.
219. Tiribelli C, Ostrow JD New concepts in bilirubin chemistry, transport and metabolism. Report of the International Bilirubin Workshop, Trieste, Italy. Hepatology 1990, 11:303.
220. Doumas BT, Wu TW The measurement of bilirubin fractions in serum. Crit Rev Clin Lab Sci 1991, 28:415.
221. Hutchinson DW, Johnson B, Knell AJ The reaction between bilirubin and aromatic diazo compounds. Biochem J 1972, 127:907.
222. Van den Bergh AAH, Muller P Ueber eine direkte und eine indirekte Diazoreaktion auf Bilirubin. Biochem Z 1916, 77:90.
223. Talafant E Properties and composition of bile pigment giving direct diazo reaction. Nature 1956, 178:312.
224. Lauff JJ, Kasper ME, Ambros RT Quantitative liquid chromatographic estimation of bilirubin species in pathological serum. Clin Chem 1983, 29:800.
225. Poon R, Hinberg IH Indican interference with six commercial procedures for measuring total bilirubin. Clin Chem 1985, 31:92.
226. Heirwegh KPM, et al. Recent advances in the separation and analysis of diazo-positive bile pigments. Methods Biochem Anal 1974, 22:205.
227. Blanckaert N, et al. Measurement of bilirubin and its mono- and diconjugates in human serum by alkaline methanolysis and high performance liquid chromatography. J Lab Clin Med 1980, 96:198.
228. Onishi S, et al. An accurate and sensitive analysis by high pressure liquid chromatography of conjugated and unconjugated bilirubin IX and in various biological fluids. Biochem J 1980, 185:281.
229. Roy Chowdhury J, et al. Bilirubin monoglucuronide and diglucuronide formation by human liver in vitro: assay by high pressure liquid chromatography. Hepatology 1981, 1:622.
230. Dappen GM, et al. A diazo-based dry film for determination of total bilirubin in serum. Clin Chem 1983, 29:37.
231. Kubasik NP, et al. The measurement of fractionated bilirubin by Ektachem film slides. Method validation and comparison of conjugated bilirubin measurements with direct bilirubin in obstructive and hepatocellular jaundice. Am J Clin Pathol 1985, 84:518.
232. Maisels MJ, Kring E Transcutaneous bilirubinometry decreases the need for serum billirubin measurement and saves money. Pediatrics 1997, 99:599.
233. Tayba R, et al. Non-invasive estimation of serum bilirubin. Pediatrics 1998, 102:28.
234. Meisel S, et al. Pleural fluid to serum bilirubin concentration ratio for the separation of transudates from exudates. Chest 1990, 98:141.
235. Gartner LM, et al. Development of bilirubin transport and metabolism in the newborn Rhesus monkey. J Pediatr 1977, 90:513.
236. Hardy JB, Peeples MO Serum bilirubin levels in newborn infants. Distributions and associations with neurological abnormalities during the first year of life. Johns Hopkins Med J 1971, 128:265.
237. Maisels MJ, et al. Endogenous production of carbon monoxide in normal and erythroblastic newborn infants. J Clin Invest 1971, 50:1.
238. 15N) glycine. Biochem J 1965, 95:11c.
239. Clarke CA, et al. Combined study: prevention of Rh hemolytic disease: final results of the "high risk" clinical trial. A combined study from centers in England and Baltimore. Br Med J 1971, 2:607.
240. Haberman S, et al. ABO isoimmunization: the use of the specific Coombs and best elution tests in the detection of hemolytic disease. J Pediatr 1960, 56:471.
241. Levi AJ, Gatmaitan Z, Arias IM Deficiency of hepatic organic anion-binding protein, impaired organic anion uptake by liver and "physiologic" jaundice in newborn monkeys. N Engl J Med 1970, 283:1136.
242. Odell GB "Physiologic" hyperbilirubinemia in the neonatal period. N Engl J Med 1967, 277:193.
243. Kawade N, Onishi S The prenatal and postnatal development of UDP-glucuronosyltransferase activity towards bilirubin and the effect of premature birth on this activity in human liver. Biochem J 1981, 196:257.
244. Gollan JL, Knapp AB Bilirubin metabolism and congenital jaundice. Hosp Pract 1985, 15:83.
245. Arthur LJH, Bevan BR, Holton JB Neonatal hyperbilirubinemia and breast feeding. Dev Med Child Neurol 1966, 8:279.
246. Maisels MJ, Newman TB Kernicterus in otherwise healthy breast-fed term newborns. Pediatrics 1995, 96:730.
247. Arias IM, et al. Prolonged neonatal unconjugated hyperbilirubinemia associated with breast feeding and a steroid, pregnana-3(alpha), 20(beta)-diol, in maternal milk that inhibits glucuronide formation in vitro. J Clin Invest 1964, 43:2037.
248. Hargreaves T, Piper RF Breast milk jaundice: effect of inhibitory breast milk and 3(alpha), 20(beta)-diol, in maternal milk that inhibits glucuronide formation in vitro. J Clin Invest 1964, 43:2037.
249. Foliot A, et al. Breast milk jaundice: in vitro inhibition of rat liver bilirubin-uridine diphosphate glucuronosyl transferase activity and Z protein- bromosulfophthalein binding by human breast milk. Pediatr Res 1976, 10:594.
250. Lucey JF, Driscol JJ Physiological jaundice re-examined. Kernicterus 1961, 29. University of Toronto Press, Toronto. A. Sass-Kortsak (Ed.).
251. Arias IM, et al. Transient familial neonatal hyperbilirubinemia. J Clin Invest 1965, 44:1442.
252. Hsia DY-T, et al. Prolonged obstructive jaundice in infancy: general survey of 156 cases. Pediatrics 1952, 10:243.
253. Poland RL, Odell GB Physiologic jaundice: the enterohepatic circulation of bilirubin. N Engl J Med 1971, 284:1.
254. Schalm L, Weber AP Jaundice with conjugated bilirubin in hyperhaemolysis. Acta Med Scand 1964, 176:549.
255. Robinson S, et al. Jaundice in thalassemia minor: a consequence of "ineffective erythropoiesis.". N Engl J Med 1962, 267:512.
256. Verwilghen R, et al. Hempas: congenital dyserythropoietic anaemia (type II). Q J Med 1973, 42:257.
257. Crigler JF, Najjar VA Congenital familial non-hemolytic jaundice with kernicterus. Pediatrics 1952, 10:169.
258. Childs B, Sidbury JB, Migeon CJ Glucuronic acid conjugation by patients with familial non-hemolytic jaundice and their relatives. Pediatrics 1959, 23:903.
259. Blaschke TF, et al. Crigler-Najjar syndrome: an unusual course with development of neurologic damage at age eighteen. Pediatr Res 1974, 8:573.
260. Arias IM, et al. Chronic nonhemolytic unconjugated hyperbilirubinemia with glucuronosyl transferase deficiency: clinical, biochemical, pharmacologic, and genetic evidence for heterogeneity. Am J Med 1969, 47:395.
261. Wolkoff AW, et al. Crigler-Najjar syndrome (type I) in an adult male. Gastroenterology 1979, 76:3380.
262. 14-bilirubin in congenital nonhemolytic jaundice. J Clin Invest 1963, 42:1720.
263. Huang PWH, et al. Crigler-Najjar syndrome in four of five siblings with post-mortem findings in one. Arch Pathol 1970, 90:536.
264. Van Es HHG, et al. Immunochemical characterization of UDP-glucuronosyltransferase in four patients with the Crigler-Najjar type I syndrome. J Clin Invest 1990, 85:1199.
265. Bosma PJ, et al. Sequence of exons and the flanking regions of human bilirubin-UDP-glucuronosyltransferase gene complex and identification of a genetic mutation in a patient with Crigler-Najjar syndrome, type I. Hepatology 1992, 15:941.
266. Bosma PJ, et al. Mechanism of inherited deficiencies of multiple UDP-glucuronosyltransferase isoforms in two patients with Crigler-Najjar syndrome, type I. FASEB J 1992, 6:2859.
267. Ritter JK, et al. Identification of a genetic alteration in the code for bilirubin UDP-glucuronosyltransferase in the UGT1 gene complex of a Crigler-Najjar syndrome, type I. J Clin Invest 1992, 90:150.
268. Kadakol A, et al. Genetic lesions of bilirubin uridinediphosphoglucuronate glucuronosyltransferase causing Crigler-Najjar and Gilbert's syndromes: correlation of genotype to phenotype. Hum Mutat 2000, 16:297.
269. Gantla S, et al. Splice site mutations: a novel genetic mechanism of Crigler-Najjar syndrome type 1. Am J Hum Genet 1998, 62:585.
270. Petit FM, et al. Parental isodisomy for chromosome 2 as the cause of Crigler-Najjar syndrome type I syndrome. Eur J Hum Genet 2005, 13:278.
271. Gunn CH Hereditary acholuric jaundice in a new mutant strain of rats. J Hered 1938, 29:137.
272. Carbone JV, Grodsky GM Constitutional nonhemolytic hyperbilirubinemia in the rat: defect of bilirubin conjugation. Proc Soc Exp Biol Med 1957, 94:461.
273. Roy Chowdhury J, Van Es HHS, Roy Chowdhury N Gunn rat: an animal model for deficiency of bilirubin conjugation. Pathophysiology of bile secretion 1992, 713. Raven Press, New York. P.D. Berk, N. Tavoloni (Eds.).
274. Blanc WA, Johnson L Studies on kernicterus. J Neuropathol Exp Neurol 1959, 18:165.
275. 3H in the rat. Am J Gastroenterol 1978, 70:259.
276. Flock EV, et al. Conjugation of thyroid hormones and analogues by the Gunn rat. Endocrinology 1965, 77:303.
277. Roy Chowdhury N, et al. Isolation and purification of multiple normal and functionally defective forms of UDP-glucuronosyltransferase from livers of inbred Gunn rats. J Clin Invest 1987, 79:327.
278. ElAwady M, et al. Mechanism of the lack of induction of UDP-glucuronosyltransferase activity by 3-methylcholanthrene in Gunn rats. J Biol Chem 1990, 265:10752.
279. Roy Chowdhury J, et al. Molecular basis for the lack of bilirubin-specific and 3-methylcholanthrene-inducible UDP-glucuronosyltransferase activities in Gunn rats: the two isoforms are encoded by distinct mRNA species that share an identical single base deletion. J Biol Chem 1991, 266:18294.
280. Gorodischer R, et al. Congenital nonobstructive, nonhemolytic jaundice: effect of phototherapy. N Engl J Med 1970, 282:375.
281. Plotz PH, et al. Removing substances from blood by affinity chromatography. I. Removing bilirubin and other albumin-bound substances from plasma and blood with albumin-conjugated agarose beads. J Clin Invest 1974, 53:778.
282. Scharschmidt BF, et al. Hemoperfusion through albumin-conjugated agarose gel for the treatment of neonatal jaundice in Rhesus monkeys. J Lab Clin Med 1977, 89:101.
283. Schauer R, et al. Treatment of Crigler-Najjar type 1 disease: relevance of early liver transplantation. J Pediatr Surg 2003, 38:1227.
284. Drummond GS, Kappas A Chemoprevention of neonatal jaundice, potency of tin protoporphyrin in an animal model. Science 1982, 217:6466.
285. Cornelius CS, Rodgers PA Prevention of neonatal hyperbilirubinemia in rhesus monkey by tinprotoporphyrin. Pediatr Res 1984, 18:728.
286. Galbraith RA, Drummond GS, Kappas A Suppression of bilirubin production in the Crigler-Najjar, type I syndrome: studies with heme oxygenase inhibitor tinmesoporphyrin. Pediatrics 1992, 89:175.
287. Lavin A, et al. Enzymatic removal of bilirubin from blood: a potential treatment for neonatal jaundice. Science 1985, 230:543.
288. Sugi K, Inoue M, Morino Y Degradation of plasma bilirubin by a bilirubin oxidase derivative which has a relatively long half-life in the circulation. Biochim Biophys Acta 1989, 991:405.
289. Wattenberg LW, Loub WD Inhibition of polycyclic aromatic hydrocarbon-induced neoplasia by naturally occurring indoles. Cancer Res 1978, 38:1410.
290. Kapitulnik J The role of cytochrome P-450 in the alternate pathways of bilirubin metabolism in congenitally jaundiced Gunn rats and infants with the Crigler-Najjar syndrome, type I 1992, International Bilirubin Workshop, Trieste, 53.
291. Roy Chowdhury J, et al. Hepatic conversion of bilirubin monoglucuronide to bilirubin diglucuronide in uridinediphosphate glucuronosyltransferase deficient man and rat by bilirubin glucuronoside glucuronosyltransferase. J Clin Invest 1978, 21:191.
292. Demetriou AA, et al. Replacement of hepatic functions in rats by transplantation of microcarrier-attached hepatocytes. Science 1986, 233:1190.
293. Gupta S, et al. Permanent engraftment and function of hepatocytes delivered to the liver: implications for gene therapy and liver repopulation. Hepatology 1991, 14:144.
294. Fox IJ, et al. Treatment of Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med 1998, 333:1422.
295. Fox IJ, Roy-Chowdhury J Hepatocyte transplantation. J Hepatol 2004, 40:878.
296. Dhawan A, et al. Human hepatocyte transplantation: current experience and future challenges. Nat Rev Gastroenterol Hepatol 2010, 7:288.
297. Roy Chowdhury J, et al. Hepatocyte transplantation in humans: gene therapy and more. Pediatrics 1998, 102:647.
298. Guha C, et al. Long-term normalization of serum bilirubin levels by massive repopulation of Gunn rat liver by normal hepatocytes, transplanted after preparative hepatic irradiation and partial hepatectomy. Hepatology 2002, 36:354.
299. Takahashi M, et al. A novel strategy for in vivo expansion of transplanted hepatocytes using preparative hepatic irradiation and FasL-induced hepatocellular apoptosis. Gene Ther 2003, 10:304.
300. Roy Chowdhury J, et al. Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDL-receptor deficient rabbits. Science 1991, 54:1802.
301. Kren B, et al. Gene therapy as an alternative for liver transplantation. Liver Transplant 2002, 8:1089.
302. Thummala NR, et al. A non-immunogenic adenoviral vector, coexpressing CTLA4Ig and bilirubin-uridinediphosphoglucuronateglucuronosyltransferase permits long-term, repeatable transgene expression in the Gunn rat model of Crigler-Najjar syndrome. Gene Ther 2002, 9:981.
303. Sauter BV, et al. Gene transfer to the liver using a replication-deficient recombinant SV40 vector results in long-term amelioration of jaundice in Gunn rats. Gastroenterology 2000, 119:1348.
304. Strayer DS, et al. Durability of transgene expression and vector integration: recombinant SV40-derived gene therapy vectors. Mol Ther 2002, 6:227.
305. Kren B, et al. Correction of the UDP-glucuronosyltransferase gene defect in the Gunn rat model of Crigler-Najjar syndrome type I. Proc Natl Acad Sci U S A 1999, 96:10349.
306. Ghosh SS, et al. Liver-directed gene therapy: promises, problems and prospects at the turn of the century. J Hepatol 2000, 32(Suppl 1):238.
307. Arias IM Chronic unconjugated hyperbilirubinemia without overt signs of hemolysis in adolescents and adults. J Clin Invest 1962, 41:2233.
308. Gollan JL, et al. Prolonged survival in three brothers with severe type II Crigler-Najjar syndrome. Ultrastructural and metabolic studies. Gastroenterology 1975, 68:1543.
309. Gordon ER, Shaffer EA, Sass-Kortsak A Bilirubin secretion and conjugation in the Crigler-Najjar syndrome type II. Gastroenterology 1976, 70:761.
310. Fevery J, et al. Unconjugated bilirubin and an increased proportion of bilirubin monoconjugates in the bile of patients with Gilbert's syndrome and Crigler-Najjar syndrome. J Clin Invest 1977, 60:970.
311. Bosma PJ, et al. A mutation in bilirubin uridine 5′-diphosphate glucuronosyltransferase isoforms 1 causing Crigler-Najjar syndrome type II. Gastroenterology 1993, 105:216.
312. Hunter JO, et al. Inheritance of type II Crigler-Najjar hyperbilirubinemia. Gut 1973, 14:46.
313. Kadakol A, et al. Interaction of coding region mutations and the gilbert-type promoter abnormality of the UGT1A1 gene causes moderate degrees of unconjugated hyperbilirubinemia and may lead to neonatal kernicterus. J Med Genet 2001, 38:244.
314. Gilbert A, Lereboullet P La cholamae simple familiale. Semin Med 1901, 21:241.
315. Foulk WT, et al. Constitutional hepatic dysfunction (Gilbert's disease): its natural history and related syndrome. Medicine (Baltimore) 1959, 38:25.
316. Arias IM, London IM Bilirubin glucuronide formation in vitro: demonstration of a defect in Gilbert's disease. Science 1957, 126:563.
317. Powell LW, et al. Idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome): a study of 42 families. N Engl J Med 1967, 277:1108.
318. Muraca M, Fevery J Influence of sex and sex steroids on bilirubin-uridinediphosphate glucuronosyltransferase activity of rat liver. Gastroenterology 1984, 87:308.
319. Bosma PJ, et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med 1995, 333:1171.
320. Monaghan G, et al. Genetic variation in bilirubin UDP-glucuronosyltransferase gene promoter and Gilbert's syndrome. Lancet 1996, 347:578.
321. Raijmakers MT, et al. Association of human liver bilirubin UDP-glucuronyltransferase activity with a polymorphism in the promoter region of the UGT1A1. J Hepatol 2000, 33:348.
322. Beutler E, Gelbart T, Demina A Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?. Proc Natl Acad Sci U S A 1998, 95:8170.
323. Maruo Y, et al. Gilbert syndrome caused by a homozygous missense mutation (Tyr486Asp) of bilirubin UDP-glucuronosyltransferase gene. J Pediatr 1998, 132:1045.
324. Koiwai O, et al. Gilbert's syndrome is caused by a heterozygous missense mutation in the gene for bilirubin UDP-glucuronosyltransferase. Hum Mol Genet 1995, 4:1183.
325. Aono S, et al. Analysis of genes for bilirubin UDP-glucuronosyltransferase in Gilbert's syndrome. Lancet 1995, 345:958.
326. Akaba K, et al. Neonatal hyperbilirubinemia and a common mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese. J Hum Genet 1999, 44:22.
327. Bancroft JD, Kreamer B, Gourley GR Gilbert syndrome accelerates development of neonatal jaundice. J Pediatr 1998, 132:656.
328. Roy-Chowdhury N, et al. Presence of the genetic marker for Gilbert syndrome is associated with increased level and duration of neonatal jaundice. Acta Paediatr 2002, 91:100.
329. Kaplan M, et al. Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia. Proc Natl Acad Sci U S A 1997, 94:12128.
330. Jansen PL, et al. Persistent unconjugated hyperbilirubinemia after liver transplantation due to an abnormal bilirubin UDP-glucuronosyltransferase gene promoter sequence in the donor. J Hepatol 1997, 27:1.
331. Vajro P, et al. Unusual early presentation of Gilbert syndrome in pediatric recipients of liver. J Pediatr Gastroenterol Nutr 2000, 31:238.
332. del Giudice EM, et al. Coinheritance of Gilbert syndrome increases the risk for developing gallstones in patients with hereditary spherocytosis. Blood 1999, 94:2259.
333. de Morais SM, Uetrecht JP, Wells PG Decreased glucuronidation and increased bioactivation of acetaminophen in Gilbert's syndrome. Gastroenterology 1992, 102:577.
334. Ullrich D, et al. Normal pathways for glucuronidation, sulphation and oxidation of paracetamol in Gilbert's syndrome. Eur J Clin Invest 1987, 17:237.
335. Wells PG, et al. Glucuronidation and the UDP-glucuronosyltransferases in health and disease. Drug Metab Dispos 2004, 32:281.
336. Iyer L, et al. Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes. J Clin Invest 1998, 101:847.
337. Billing BH, Williams R, Richards TG Defects in hepatic transport of bilirubin in congenital hyperbilirubinaemia. An analysis of plasma bilirubin disappearance curves. Clin Sci 1964, 27:245.
338. Goresky CA, et al. Definition of a conjugation dysfunction in Gilbert's syndrome: studies of the handling of bilirubin loads and of the pattern of bilirubin conjugates secreted in bile. Clin Sci Mol Med 1978, 1:63.
339. Cobelli C Modeling, identification and parameter estimation of bilirubin kinetics in normal, hemolytic and Gilbert's states. Comput Biomed Res 1975, 8:522.
340. Berk PD, Blaschke TF, Waggoner JG Defective BSP clearance in patients with constitutional hepatic dysfunction (Gilbert's syndrome). Gastroenterology 1972, 63:472.
341. Cobelli C, et al. BSP vs bilirubin kinetics in Gilbert's syndrome. Familial hyperbilirubinemia 1981, 121. Wiley, New York. L. Okolicsanyl (Ed.).
342. Gollan J, Bateman C, Billing BH Effect of dietary composition on the unconjugated hyperbilirubinemia of Gilbert's syndrome. Gut 1976, 5:335.
343. Felsher BR, Carpio NM Caloric intake and unconjugated hyperbilirubinemia. Gastroenterology 1975, 69:42.
344. Bensinger TA, et al. Effect of low caloric diet on endogenous carbon monoxide production: normal adults and Gilbert's syndrome. Proc Soc Exp Biol Med 1973, 144:417.
345. Gollan JL, Hatt KJ, Billing BH The influence of diet on unconjugated hyperbilirubinemia in the Gunn rat. Clin Sci Mol Med 1975, 49:229.
346. Lundh B, et al. Enhancement of heme catabolism by caloric restriction in man. Scand J Clin Lab Invest 1972, 30:421.
347. Kotal P, Vitek L, Fevery J Fasting-related hyperbilirubinemia in rats: the effect of decreased intestinal motility. Gastroenterology 1996, 111:217.
348. Kirschebaum G, Shames DM, Schmid R An expanded model of bilirubin kinetics: effect of feeding, fasting and phenobarbital in Gilbert's syndrome. J Pharmacokinet Biopharm 1976, 2:115.
349. Laperche Y, et al. Effect of fasting on organic anion uptake by isolated rat liver cells. Hepatology 1981, 1:617.
350. Cowan RE, et al. The association between fasting hyperbilirubinaemia and serum non-esterified fatty acids in man. Clin Sci Mol Med 1977, 53:155.
351. Sorrenito D, et al. The hepatocellular uptake of free fatty acid is selectively preserved during starvation. Gastroenterology 1994, 107:1415.
352. Ishihara T, et al. Role of UGT1A1 mutation in fasting hyperbilirubinemia. J Gastroenterol Hepatol 2001, 16:678.
353. Felscher BF, Carpio NM, Van Couvering K Effect of fasting and phenobarbital on hepatic UDP-glucuronic acid formation in the rat. J Lab Clin Med 1979, 93:414.
354. Ohkubo H, Musha H, Okuda K Studies on nicotinic acid interaction with bilirubin metabolism. Dig Dis Sci 1979, 24:700.
355. Fromke VL, Miller D Constitutional hepatic dysfunction (CHD: Gilbert's disease): a review with special reference to a characteristic increase and prolongation of the hyperbilirubinemic response to nicotinic acid. Medicine (Baltimore) 1972, 51:451.
356. Davidson AR, et al. Reduced caloric intake and nicotinic acid provocation tests in diagnosis of Gilbert's syndrome. Br Med J 1975, 2:480.
357. Portman OW, et al. A non-human primate model for Gilbert's syndrome. Hepatology 1984, 4:175.
358. Portman OW, et al. Effects of nutrition on hyperbilirubinemia in Bolivian squirrel monkeys. Hepatology 1984, 4:454.
359. Zimmerman HJ Drug-induced liver disease. Clin Liver Dis 2000, 4:73.
360. Berr F, Simon FR, Reichen J Ethynylestradiol impairs bile salt uptake and Na-K pump function of rat hepatocytes. Am J Physiol 1984, 247:G437.
361. Rosario J, et al. Ethinylestradiol administration selectively alters liver sinusoidal membrane lipid fluidity and protein composition. Biochemistry 1988, 27:3939.
362. Stieger B, et al. Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (bsep) of rat liver. Gastroenterology 2000, 118:422.
363. Bossard R, et al. Ethinylestradiol treatment induces multiple canalicular membrane transport alterations in rat liver. J Clin Invest 1993, 91:2714.
364. Huang L, et al. MRP2 is essential for estradiol-17 beta (beta- d-glucuronide)-induced cholestasis in rats. Hepatology 2000, 32:66.
365. Simon FR, et al. Ethinylestradiol cholestasis involves alterations in expression of liver sinusoidal transporters. Am J Physiol 1996, 271:G1043.
366. Lai K, Harnish DC, Evans MJ Estrogen receptor α regulates expression of the orphan receptor small heterodimer partner. J Biol Chem 2003, 278:36418.
367. Fiorucci S, et al. Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid X receptor ligand, in estrogen induced cholestasis. J Pharmacol Exp Ther 2005, 313:604.
368. Lee JM, et al. Expression of the bile salt export pump is maintained after chronic cholestasis in the rat. Gastroenterology 2000, 118:163.
369. Hirohashi T, et al. ATP-dependent transport of bile salts by rat multidrug resistance-associated protein 3 (mrp3). J Biol Chem 2000, 275:2905.
370. +-taurocholate cotransport and its encoding messenger RNA in primary cultures of rat hepatocytes. Hepatology 1993, 18:1162.
371. Bohme M, et al. Differential inhibition by cyclosporins of primary-active ATP-dependent transporters in the hepatocyte canalicular membrane. FEBS Lett 1993, 333:193.
372. Stone BG, et al. Cyclosporin A-induced cholestasis. The mechanism in a rat model. Gastroenterology 1987, 93:344.
373. Dubin IN, Johnson FB Chronic idiopathic jaundice with unidentified pigment in liver cells: a new clinocopathologic entity with a report of 12 cases. Medicine (Baltimore) 1954, 33:155.
374. Sprinz H, Nelson RS Persistent nonhemolytic hyperbilirubinemia associated with lipochrome-like pigment in liver cells: report of four cases. Ann Intern Med 1954, 41:952.
375. Dubin IN Chronic idiopathic jaundice: a review of fifty cases. Am J Med 1958, 23:268.
376. Shani M, et al. Dubin-Johnson syndrome in Israel. I. Clinical laboratory, and genetic aspects of 101 cases. West J Med 1970, 39:549.
377. Cohen L, Lewis C, Arias IM Pregnancy, oral contraceptives, and chronic familial jaundice with predominantly conjugated hyperbilirubinemia (Dubin-Johnson syndrome). Gastroenterology 1972, 62:1182.
378. Nakata F, et al. Dubin-Johnson syndrome in a neonate. Eur J Pediatr 1979, 132:299.
379. Morita M, Kihava T Intravenous cholecystography and metabolism of meglumine iodipamide (biligrafin) in Dubin-Johnson syndrome. Radiology 1971, 99:57.
380. Muscatello U, Mussini L, Agnolucci MT The Dubin-Johnson syndrome: an electronmicroscopic study of the liver cell. Acta Hepatosplen 1967, 14:162.
381. Wegmann R, et al. Melanose hepato-splenique avec ictere chronique a bilirubine directe: maladie de Dubin-Johnson? Etude clinique et biologique de la maladie. Etudie histochimique, chimique et spectographique du pigment anormal. Semin Hop Paris 1960, 26:1761.
382. Arias IM, et al. Black liver diseases in Corriedale sheep: metabolism of tritiated epinephrine and incorporation of isotope into the hepatic pigment in vivo. J Clin Invest 1965, 44:1026.
383. Swartz HM, Sarna T, Varma RR On the nature and excretion of the hepatic pigment in the Dubin-Johnson syndrome. Gastroenterology 1979, 76:958.
384. Arias IM, Blumberg W The pigment in Dubin-Johnson syndrome. Gastroenterology 1979, 77:820.
385. Swartz HM, Sarnat T, Varma RR The pigment in Dubin-Johnson syndrome. Gastroenterology 1979, 77:821.
386. Ware A, et al. Dubin-Johnson syndrome and viral hepatitis. Gastroenterology 1974, 67:560.
387. Schoenfield LJ, et al. Studies of chronic idiopathic jaundice (Dubin-Johnson syndrome). I. Demonstration of hepatic excretory defect. Gastroenterology 1963, 44:101.
388. Rodes J, Zubizarreta A, Bruguera M Metabolism of the bromsulphalein in Dubin-Johnson syndrome. Diagnostic value of the paradoxical in plasma levels of BSP. Dig Dis 1972, 17:545.
389. Machida I, et al. Mutation analysis of the multidrug resistance protein 2 (MRP2) gene in a Japanese patient with Dubin-Johnson syndrome. Hepatol Res 2004, 30:86-90.
390. Keitel V, et al. Impaired protein maturation of the conjugate export pump multidrug resistance protein 2 as a consequence of a deletion mutation in Dubin-Johnson syndrome. Hepatology 2000, 32:1317.
391. Bohan A, Boyer JL Mechanisms of hepatic transport of drugs: implications for cholestatic drug reactions. Semin Liver Dis 2002, 22:123.
392. -) rats with conjugated hyperbilirubinemia. Proc Natl Acad Sci U S A 1990, 87:3557.
393. - rats. J Hepatol 1999, 31:678.
394. -) rats: relation to the pathogenesis of black liver in the Dubin-Johnson syndrome and Corriedale sheep with an analogous excretory defect. Hepatology 1992, 15:1154.
395. - rats with a hepatobiliary secretion defect. Am J Physiol 1993, 265:G445.
396. Borst P, et al. The multidrug resistance protein family. Biochim Biophys Acta 1999, 1461:347.
397. Kool M, et al. Expression of human MRP6, a homologue of the multidrug resistance protein gene MRP1, in tissues and cancer cells. Cancer Res 1999, 59:175.
398. Seligsohn U, et al. Dubin-Johnson syndrome in Israel. II. Association with factor-VII deficiency. Q J Med 1970, 39:569.
399. Levanon M, et al. Active and inactive factor-VII in Dubin-Johnson syndrome with factor-VII deficiency, hereditary factor-VII deficiency and on coumadin administration. Br J Haematol 1972, 23:669.
400. Kaplowitz N, Javitt N, Kappas A Coproporphyrin I and III excretion in bile and urine. J Clin Invest 1972, 51:2895.
401. Wolkoff AW, Cohen LE, Arias IM Inheritance of the Dubin-Johnson syndrome. N Engl J Med 1973, 288:113.
402. Kondo T, Kuchiba K, Shimizu Y Coproporphyrin isomers in Dubin-Johnson syndrome. Gastroenterology 1976, 70:1117.
403. Wolkoff AW, Arias IM Coproporphyrin excretion in amniotic fluid and urine from premature infants: a possible maturation defect. Pediatr Res 1974, 8:591.
404. Cornelius CE, Arias IM, Osburn BI Hepatic pigmentation with photosensitivity: a syndrome in Corriedale sheep resembling Dubin-Johnson syndrome in man. J Am Vet Med Assoc 1965, 146:709.
405. Alpert S, et al. Multiplicity of hepatic excretory mechanisms for organic anions. J Gen Physiol 1969, 53:238.
406. Barnhart JL, Gronwall RR, Combes B Biliary excretion of sulfobromophthalein compounds in normal and mutant Corriedale sheep. Evidence for a disproportionate transport defect for conjugated sulfobromophthalein. Hepatology 1981, 1:441.
407. Arias IM, et al. Black liver disease in Corriedale sheep: metabolism of tritiated epinephrine and incorporation of isotope into the hepatic pigment in vivo. J Clin Invest 1965, 44:1026.
408. Jansen PLM, Peters WHM, Lamers WH Hereditary chronic conjugated hyperbilirubinemia in mutant rats caused by defective hepatic anion transport. Hepatology 1985, 5:573.
409. Jansen PLM, et al. Selective hepatobiliary transport defect for organic anions and neutral steroids in mutant rats with hereditary conjugated hyperbilirubinemia. Hepatology 1987, 7:71.
410. Jansen PLM, et al. Preserved organic anion transport in mutant TR-rats with a hepatobiliary secretion defect. Am J Physiol 1993, 265:G445.
411. Ito K, et al. Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR. Am J Physiol 1997, 272:G16.
412. Rotor AB, Manahan L, Florentin A Familial nonhemolytic jaundice with direct van den Bergh reaction. Acta Med Phil 1948, 5:37.
413. Wolkoff AW, et al. Rotor's syndrome: a distinct inheritable pathophysiologic entity. Am J Med 1976, 60:173.
414. Pereira-Lima JE, Utz E, Rosenberg I Hereditary nonhemolytic conjugated hyperbilirubinemia without abnormal liver cell pigmentation. A family study. Am J Med 1966, 40:628.
415. Wolpert E, et al. Abnormal sulfobromophthalein metabolism in Rotor's syndrome and obligate heterozygotes. N Engl J Med 1977, 296:1099.
416. Schiff L, Billing BH, Oikawa Y Familial nonhemolytic jaundice with conjugated bilirubin in the serum. N Engl J Med 1959, 260:1315.
417. Kawasaki H, et al. Dye clearance studies in Rotor's syndrome. Am J Gastroenterol 1979, 71:380.
418. Hadchouel P, et al. A propos d'une nouvelle forme d'ictere chronique idiopathique. Hypothese physiopathologique. Rev Med Chir Mal Foie 1971, 46:61.
419. Dhumeaux D, Berthelot P Chronic hyperbilirubinemia associated with hepatic uptake and storage impairment: a new syndrome resembling that of the mutant Southdown sheep. Gastroenterology 1975, 69:988.
420. Rapacini GL, et al. Porphyrins in Rotor syndrome: a study on an Italian family. Hepato-Gastroenterol 1986, 33:11.
421. Akaba K, et al. Neonatal hyperbilirubinemia and a common mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese. J Hum Genet 1999, 44:22. (Ref.326).
422. Bancroft JD, Kreamer B, Gourley GR Gilbert syndrome accelerates development of neonatal jaundice. J Pediatr 1998, 132:656. (Ref.327).
423. Battaglia E, Radominska-Pandya A A functional role for histidyl residues of the UDP-glucuronic acid carrier in rat liver endoplasmic reticulum membranes. Biochemistry 1998, 37:258. (Ref.159).
424. Beigneux AP, et al. The acute phase response is associated with retinoid X receptor repression in rodent liver. J Biol Chem 2000, 275:16390. (Ref.136).
425. Beutler E, Gelbart T, Demina A Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?. Proc Natl Acad Sci U S A 1998, 95:8170. (Ref.322).
426. Bohan A, Boyer JL Mechanisms of hepatic transport of drugs: implications for cholestatic drug reactions. Semin Liver Dis 2002, 22:123. (Ref.391).
427. Borst P, et al. The multidrug resistance protein family. Biochim Biophys Acta 1999, 1461:347. (Ref.396).
428. Brink MA, et al. Enterohepatic cycling of bilirubin: a putative mechanism for pigment gallstone formation in ileal Crohn's disease [see comments]. Gastroenterology 1999, 116:1420. (Ref.33).
429. Brito MA, et al. Bilirubin injury to neurons: contribution of oxidative stress and rescue by glycoursodeoxycholic acid. Neurotoxicology 2008, 29:259. (Ref.94).
430. Cesaratto L, et al. Bilirubin-induced cell toxicity involves PTEN activation through an APE1/Ref-1-dependent pathway. J Mol Med 2007, 85:1099. (Ref.95).
431. Cui Y, et al. Hepatic uptake of bilirubin and its conjugates by the human organic anion-transporting polypeptide 2 (symbol SLC21A6). J Biol Chem 2000, 276:9626. (Ref.128).
432. de Vree JM, et al. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc Natl Acad Sci U S A 1998, 95:282. (Ref.199).
433. Deganuto M, et al. A proteomic approach to the bilirubin-induced toxicity in neuronal cells reveals a protective function of DJ-1 protein. Proteomics 2010, 10:1645. (Ref.96).
434. del Giudice EM, et al. Coinheritance of Gilbert syndrome increases the risk for developing gallstones in patients with hereditary spherocytosis. Blood 1999, 94:2259. (Ref.332).
435. Denson LA, et al. Interleukin-1α suppresses retinoid transactivation of two hepatic transporter genes involved in bile formation. J Biol Chem 2000, 275:8835. (Ref.134).
436. Dhawan A, et al. Human hepatocyte transplantation: current experience and future challenges. Nat Rev Gastroenterol Hepatol 2010, 7:288. (Ref.296).
437. Dranoff JA, et al. Short-term regulation of bile acid uptake by microfilament-dependent translocation of rat ntcp to the plasma membrane. Hepatology 1999, 30:223. (Ref.132).
438. Fernandez M, Bonkovsky HL Increased heme oxygenase-1 gene expression in liver cells and splanchnic organs from portal hypertensive rats. Hepatology 1999, 29:1672. (Ref.15).
439. Fiorucci S, et al. Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid X receptor ligand, in estrogen induced cholestasis. J Pharmacol Exp Ther 2005, 313:604. (Ref.367).
440. Fox IJ, et al. Treatment of Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med 1998, 333:1422. (Ref.294).
441. Fox IJ, Roy-Chowdhury J Hepatocyte transplantation. J Hepatol 2004, 40:878. (Ref.295).
442. Fulks M, Stout RL, Dolan VF Mortality associated with bilirubin levels in insurance applicants. J Insur Med 2009, 41:49. (Ref.27).
443. Ganguly TC, et al. Regulation of the rat liver sodium-dependent bile acid cotransporter gene by prolactin. Mediation of transcriptional activation by Stat5. J Clin Invest 1997, 99:2906. (Ref.133).
444. Gantla S, et al. Splice site mutations: a novel genetic mechanism of Crigler-Najjar syndrome type 1. Am J Hum Gen 1998, 62:585. (Ref.269).
445. Gerloff T, et al. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J Biol Chem 1998, 273:10046. (Ref.192).
446. Ghosh SS, et al. Liver-directed gene therapy: promises, problems and prospects at the turn of the century. J Hepatol 2000, 32(Suppl 1):238-252. (Ref.306).
447. Green RM, Hoda F, Ward KL Molecular cloning and characterization of the murine bile salt export pump. Gene 2000, 241:117. (Ref.195).
448. Guha C, et al. Long-term normalization of serum bilirubin levels by massive repopulation of Gunn rat liver by normal hepatocytes, transplanted after preparative hepatic irradiation and partial hepatectomy. Hepatology 2002, 36:354. (Ref.298).
449. Hirohashi T, et al. Hepatic expression of multidrug resistance-associated protein-like proteins maintained in Eisai hyperbilirubinemic rats. Mol Pharmacol 1998, 53:1068. (Ref.184).
450. Hirohashi T, Suzuki H, Sugiyama Y Characterization of the transport properties of cloned rat multidrug resistance-associated protein 3 (MRP3). J Biol Chem 1999, 274:15181. (Ref.141).
451. Hirohashi T, et al. ATP-dependent transport of bile salts by rat multidrug resistance-associated protein 3 (mrp3). J Biol Chem 2000, 275:2905. (Ref.369).
452. Huang L, et al. MRP2 is essential for estradiol-17 beta (beta-d-glucuronide)-induced cholestasis in rats. Hepatology 2000, 32:66. (Ref.364).
453. Huang W, et al. Induction of bilirubin clearance by the constitutive androstane receptor. Proc Natl Acad Sci U S A 2003, 100:4156. (Ref.201).
454. Ishihara T, et al. Role of UGT1A1 mutation in fasting hyperbilirubinemia. J Gastroenterol Hepatol 2001, 16:678. (Ref.352).
455. Iyer L, et al. Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes. J Clin Invest 1998, 101:847. (Ref.336).
456. Jedlitschky G, et al. ATP-dependent transport of bilirubin glucuronides by the multidrug resistance protein MRP1 and its hepatocyte canalicular isoform MRP2. Biochem J 1997, 327:305. (Ref.137).
457. Kadakol A, et al. Genetic lesions of bilirubin uridinediphosphoglucuronate glucuronosyltransferase causing Crigler-Najjar and Gilbert's syndromes: correlation of genotype to phenotype. Hum Mutat 2000, 16:297. (Ref.268).
458. Kadakol A, et al. Interaction of coding region mutations and the Gilbert-type promoter abnormality of the UGT1A1 gene causes moderate degrees of unconjugated hyperbilirubinemia and may lead to neonatal kernicterus. J Med Genet 2001, 38:244. (Ref.313).
459. Kamisako T, et al. Transport of monoglucuronosyl and bisglucuronosyl bilirubin by recombinant human and rat multidrug resistance protein 2. Hepatology 1999, 30:485. (Ref.179).
460. Kauffman HM, et al. Influence of redox-active compounds and PXR-activators on human MRP1 and MRP2 gene expression. Toxicology 2002, 171:137. (Ref.189).
461. Kauffmann HM, Schrenk D Sequence analysis and functional characterization of the 5′-flanking region of the rat multidrug resistance protein 2 (mrp2) gene. Biochem Biophys Res Commun 1998, 245:325. (Ref.191).
462. Keitel V, et al. Impaired protein maturation of the conjugate export pump multidrug resistance protein 2 as a consequence of a deletion mutation in Dubin-Johnson syndrome. Hepatology 2000, 32:1317. (Ref.390).
463. Keppler D, Konig J Hepatic secretion of conjugated drugs and endogenous substances. Semin Liver Dis 2000, 20:265. (Ref.186).
464. Konig J, et al. Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane. Hepatology 1999, 29:1156. (Ref.140).
465. Kool M, et al. Expression of human MRP6, a homologue of the multidrug resistance protein gene MRP1, in tissues and cancer cells. Cancer Res 1999, 59:175. (Ref.397).
466. Kouzuki H, et al. Contribution of sodium taurocholate co-transporting polypeptide to the uptake of its possible substrates into rat hepatocytes. J Pharmacol Exp Ther 1998, 286:1043. (Ref.126).
467. Kren B, et al. Correction of the UDP-glucuronosyltransferase gene defect in the Gunn rat model of Crigler-Najjar syndrome type I. Proc Natl Acad Sci USA 1999, 96:10349. (Ref.305).
468. Kren B, et al. Gene therapy as an alternative for liver transplantation. Liver Transplant 2002, 8:1089. (Ref.301).
469. Kubitz R, et al. Benign recurrent intrahepatic cholestasis associated with mutations of the bile salt export pump. J Clin Gastroenterol 2006, 40:171. (Ref.197).
470. Lai K, Harnish DC, Evans MJ Estrogen receptor α regulates expression of the orphan receptor small heterodimer partner. J Biol Chem 2003, 278:36418-36429. (Ref.366).
471. Lecureur V, et al. Cloning and expression of murine sister of P-glycoprotein reveals a more discriminating transporter than MDR1/P-glycoprotein. Mol Pharmacol 2000, 57:24. (Ref.194).
472. Lee JM, et al. Expression of the bile salt export pump is maintained after chronic cholestasis in the rat. Gastroenterology 2000, 118:163. (Ref.368).
473. Lin Y-C, et al. Variants in the UGT1A1 gene and the risk of pediatric nonalcoholic fatty liver disease. Peditrics 2009, 124:e1221. (Ref.31).
474. Machida I, et al. Mutation analysis of the multidrug resistance protein 2 (MRP2) gene in a Japanese patient with Dubin-Johnson syndrome. Hepatol Res 2004, 30:86. (Ref.389).
475. Makino N, et al. Altered expression of heme oxygenase-1 in the livers of patients with portal hypertensive diseases. Hepatology 2001, 33:32. (Ref.14).
476. Maruo Y, et al. Gilbert syndrome caused by a homozygous missense mutation (Tyr486Asp) of bilirubin UDP-glucuronosyltransferase gene. J Pediatr 1998, 132:1045. (Ref.323).
477. - rats. J Hepatol 1999, 31:678. (Ref.393).
478. Nakao A, et al. Biliverdin protects the functional integrity of a transplanted syngeneic small bowel. Gastroenterology 2004, 127:595. (Ref.25).
479. Nishikawa Y, et al. In vivo role of heme oxygenase in ischemic coronary vasodilation. Am J Physiol Heart Circ Physiol 2004, 286:H2296. (Ref.16).
480. Ogawa K, et al. Characterization of inducible nature of MRP3 in rat liver. Am J Physiol Gastrointest Liver Physiol 2000, 278:G438. (Ref.185).
481. Petit FM, et al. Parental isodisomy for chromosome 2 as the cause of Crigler-Najjar syndrome type I syndrome. Eur J Hum Genet 2005, 13:278. (Ref.270).
482. Raijmakers MT, et al. Association of human liver bilirubin UDP-glucuronyltransferase activity with a polymorphism in the promoter region of the UGT1A1. J Hepatol 2000, 33:348. (Ref.321).
483. Rao VV, et al. Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal fluid-drug permeability barrier. Proc Natl Acad Sci U S A 1999, 96:3900. (Ref.91).
484. Rattan S, Al Haj R, De Godoy MA Mechanism of internal anal sphincter relaxation by CORM-1, authentic CO, and NANC nerve stimulation. Am J Physiol Gastrointest Liver Physiol 2004, 287:G605. (Ref.17).
485. Roy-Chowdhury J, Locker J, Roy-Chowdhury N Nuclear receptors orchestrate detoxification pathways. Dev Cell 2003, 4:607. (Ref.202).
486. Roy-Chowdhury J, et al. Hepatocyte transplantation in humans: gene therapy and more. Pediatrics 1998, 102:647. (Ref.297).
487. Roy-Chowdhury N, et al. Presence of the genetic marker for Gilbert syndrome is associated with increased level and duration of neonatal jaundice. Acta Paediatr 2002, 91:100. (Ref.328).
488. Sauter BV, et al. Gene transfer to the liver using a replication-deficient recombinant SV40 vector results in long-term amelioration of jaundice in Gunn rats. Gastroenterology 2000, 119:1348. (Ref.303).
489. Schauer R, et al. Treatment of Crigler-Najjar type 1 disease: relevance of early liver transplantation. J Pediatr Surg 2003, 38:1227. (Ref.283).
490. Stieger B, et al. Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (bsep) of rat liver. Gastroenterology 2000, 118:422. (Ref.362).
491. Stockel B, et al. Characterization of the 5′-flanking region of the human multidrug resistance protein 2 (MRP2) gene and its regulation in comparison with the multidrug resistance protein 3 (MRP3) gene. Eur J Biochem 2000, 267:1347. (Ref.187).
492. Strautnieks SS, et al. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet 1998, 20:233. (Ref.193).
493. Strayer DS, et al. Durability of transgene expression and vector integration: recombinant SV40-derived gene therapy vectors. Mol Ther 2002, 6:227. (Ref.304).
494. Suzuki H, Sugiyama Y Transport of drugs across the hepatic sinusoidal membrane: sinusoidal drug influx and efflux in the liver. Semin Liver Dis 2000, 20:251. (Ref.129).
495. Takahashi M, et al. A novel strategy for in vivo expansion of transplanted hepatocytes using preparative hepatic irradiation and FasL-induced hepatocellular apoptosis. Gene Ther 2003, 10:304. (Ref.299).
496. Tanaka T, et al. The human multidrug resistance protein 2 gene: functional characterization of the 5′-flanking region and expression in hepatic cells. Hepatology 1999, 30:1507. (Ref.190).
497. Tanaka Y, et al. Increased renal expression of bilivubin glucronide transporters in a rat model of obstructive jaundice. Am J Physiol Gastrointest Liver Physiol 2002, 282:G656. (Ref.210).
498. Tayba R, et al. Non-invasive estimation of serum bilirubin. Pediatrics 1998, 102:28. (Ref.235).
499. Temme EHM, et al. Serum bilirubin and 10-year mortality risk in a Belgian population. Cancer Causes Control 2001, 12:887. (Ref.30).
500. Thummala NR, et al. A non-immunogenic adenoviral vector, coexpressing CTLA4Ig and bilirubin-uridinediphosphoglucuronateglucuronosyltransferase permits long-term, repeatable transgene expression in the Gunn rat model of Crigler-Najjar syndrome. Gene Ther 2002, 9:981. (Ref.302).
501. Trauner M, et al. Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors. J Clin Invest 1998, 101:2092. (Ref.135).
502. Trauner M, et al. The rat canalicular conjugate export pump (mrp2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology 1997, 113:255. (Ref.139).
503. Vajro P, et al. Unusual early presentation of Gilbert syndrome in pediatric recipients of liver. J Pediatr Gastroenterol Nutr 2000, 31:238. (Ref.331).
504. Van Aubel RA, et al. Expression and immunolocalization of multidrug resistance protein 2 in rabbit small intestine. Eur J Pharmacol 2000, 400:195. (Ref.178).
505. Van Aubel RA, et al. Multidrug resistance protein Mrp2 mediates ATP-dependent transport of classic renal organic anion p-aminohippurate. Am J Physiol Renal Physiol 2000, 279:F713. (Ref.177).
506. Van Mil SW, et al. Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11. Gastroenterology 2004, 127:379. (Ref.196).
507. Vos TA, et al. Up-regulation of the multidrug resistance genes, mrp1 and mdr1b, and down-regulation of the organic anion transporter, mrp2, and the bile salt transporter, spgp, in endotoxemic rat liver. Hepatology 1998, 28:1637. (Ref.138).
508. Vos TA, et al. Regulation of hepatic transport systems involved in bile secretion during liver regeneration in rats. Hepatology 1999, 29:1833. (Ref.183).
509. Wang P, et al. The human organic anion transport protein SLC21A6 (OATP2) is not sufficient for bilirubin transport. J Biol Chem 2003, 278:20695. (Ref.130).
510. +/taurocholate cotransport polypeptide is mediated via the phosphoinositide 3-kinase signaling pathway. J Biol Chem 2000, 275:29754. (Ref.131).
511. Wegiel B, et al. Cell surface biliverdin reductase mediates biliverdin-induced anti-inflammatory effects via phosphatidylinositol 3-kinase and Akt. J Biol Chem 2009, 284:21369. (Ref.32).
512. Wells PG, et al. Glucuronidation and the UDP-glucuronosyltransferases in health and disease. Drug Metab Dispos 2004, 32:281. (Ref.335).
513. Wijnholds J, et al. Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier. J Clin Invest 2000, 105:279. (Ref.92).
514. Yamashita K, et al. Biliverdin, a natural product of heme catabolism, induces tolerance to cardiac allografts. FASEB J 2004, 18:765. (Ref.26).
515. Zhang Y, et al. Expression of various multidrug resistance-associated protein (MRP) homologues in brain microvessel endothelial cells. Brain Res 2000, 876:148. (Ref.93).
516. Zimmerman HJ Drug-induced liver disease. Clin Liver Dis 2000, 4:73-96. (Ref.359).
517. Zucker SD, Goessling W Mechanism of hepatocellular uptake of albumin-bound bilirubin. Biochim Biophys Acta 2000, 1463:197. (Ref.127).
518. Zucker SD, Horn PS, Serman KE Serum bilirubin levels in the US population: gender effect and inverse correlation with colorectal cancer. Hepatology 2004, 40:827. (Ref.29).